Orthopediatrics director Pritzker sells $6.35m in shares

Orthopediatrics Corp. director Jennifer Pritzker transacted the sale of 302,369 shares of the company's common stock on September 10, 2026, according to financial filings. The shares were traded at prices ranging between $21.00 and $21.69, with the weighted average price being $21.01. This sale generated approximately $6,352,772, and Pritzker's actions were carried out by Squadron Capital LLC, a LLC under her management.

Squadron Capital utilized these funds to bolster its other portfolio businesses. Pritzker, as a 10% owner and a member of Squadron's Managing Committee, may be considered a beneficial owner of these securities. Nevertheless, she expressly denies beneficial ownership beyond her direct pecuniary interest. Post this transaction, Ms. Pritzker's indirect beneficial stake in Orthopediatrics Corp. stands at 6,201,764 shares held by Squadron Capital LLC, in addition to her direct holding of 10,900 shares.

She also has indirect holdings through various foundations and her spouse, totaling 5,800 shares. Despite these holdings, Ms. Pritzker disclaims beneficial ownership except for her direct financial interest. Orthopediatrics Corp., currently valued at $562.93 million with a 21% return over the past six months, has posted solid revenue growth, with earnings climbing to $252.72 million in the past year, even though the company remains unprofitable.

The firm forecasted a 15% increase in second-quarter revenue, reaching $70.5 million, surpassing the anticipated $68.22 million. Growth in trauma care, deformity treatment, and specialty bracing was credited for this surge, while the declining scoliosis revenue did not significantly impact the overall performance.